LINC00675 locates in chromosome 17 and has been reported to be abnormally expressed in multiple types of cancers, such as pancreatic ductal adenocarcinoma, gastric cancer, glioma, cervical cancer, esophageal squamous cell carcinoma, and prostate cancer [10–15]. Here, TMEM238L is linked to prostate carcinoma.